A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
Baylor College of Medicine
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Washington University School of Medicine
AIDS Malignancy Consortium
Masonic Cancer Center, University of Minnesota